ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 950,17
0,11%
Dow Jones
44 909,04
0,06%
DAX
21 732,05
0,01%
Brent Oil
75,645
-0,53%
Bitcoin
104 801,99
0,06%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE

  6. Takeda Pharmaceutical Co Ltd (0RN3) Cours

Takeda Pharmaceutical Co Ltd

Takeda Pharmaceutical Co Ltd (0RN3)

LSE
49,35
0,00
(0,00%)
Fermé 31 Janvier 5:30PM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
49,35
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
0,00
0,00 Fourchette du Jour 0,00
49,35 Plage de 52 semaines 49,35
Cap du marché
78,092B
Clôture Veille
49,35
Ouverture
-
Dernière Transaction
(O)
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
0,00
Actions en circulation
1 582 419 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
0,29
Bénéfice par action (BPA)
91,04
Chiffre d'affairess
4,28T
Bénéfice net
144,07B

À propos de Takeda Pharmaceutical Co Ltd

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Diversified
Site Web
www.takeda.co.jp
Siège social
Chuo, Tokyo, Jpn
Fondé
1984
Takeda Pharmaceutical Co Ltd est coté dans le secteur Pharmaceutical Preparations de la London Stock Exchange avec le ticker 0RN3. Le dernier cours de clôture d'Takeda Pharmaceutical était de 49,35 €. Au cours de la dernière année, les actions de Takeda Pharmaceutical ont été négociées dans une fourchette de prix de 49,35 € à 49,35 €.

Takeda Pharmaceutical compte actuellement 1 582 419 000 actions en circulation. La capitalisation boursière d'Takeda Pharmaceutical est de 78,09 € milliard. Takeda Pharmaceutical a un ratio cours/bénéfice (ratio PE) de 0.29.

0RN3 Dernières nouvelles

Plus de nouvelles

Takeda Pharmaceutical raises profit forecast, names Julie Kim as CEO

Takeda Pharmaceutical Co Ltd raised its earnings guidance and named a new chief executive officer as it reported a bo ...

30 Janvier 2025
Alliance News

IN BRIEF: Takeda signs exclusive licensing agreement for elritercept

ical Co Ltd - Tokyo, Japan-based pharmaceutical company - Signs agreement to further develop, manufacture and commerci ...

03 Décembre 2024
Alliance News

Hutchmed to get payment from Takeda as Fruzaqla launched in Japan

Hutchmed (China) Ltd on Friday said it will receive a milestone payment from Takeda Pharmaceutical Co Ltd after Taked ...

22 Novembre 2024
Alliance News

TOP NEWS: Takeda lifts outlook, eyes return to sustainable growth

Takeda Pharmaceutical Co Ltd on Thursday raised full year forecasts to reflect a stronger than anticipated first-half ...

31 Octobre 2024
Alliance News

Takeda Pharmaceutical says Fruzaqla cancer drug gets Japan backing

Takeda Pharmaceutical Co Ltd on Tuesday said it landed an approval for its Fruzaqla drug in Japan. The drug has bee ...

24 Septembre 2024
Alliance News

IN BRIEF: Hutchmed China notes Takeda obtains EU approval for Fruzaqla

Ltd - Hong Kong-headquartered biopharmaceutical company - Notes that Takeda Pharmaceuticals Co Ltd received a notifica ...

24 Juin 2024
Alliance News

TOP NEWS: Takeda Pharmaceutical profit sinks as expenses mount

Takeda Pharmaceutical Co Ltd on Thursday said annual revenue increased, though profit plummeted on increased expenses ...

09 Mai 2024
Alliance News

Takeda, Astellas and Sumitomo to create new drug discovery company

Takeda Pharmaceutical Co Ltd, Astellas Pharma Inc and Sumitomo Mitsui Financial Group Inc on Monday agreed to establi ...

22 Avril 2024
Alliance News

Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE

Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE PR Newswire DUBAI, UAE, March 27, 2024 Takeda's 'In Their Shoes' initiative illuminates the daily...

27 Mars 2024
PR Newswire (US)

Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE

Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE PR Newswire DUBAI, UAE, March 27, 2024 Takeda's 'In Their Shoes' initiative illuminates the daily...

27 Mars 2024
PR Newswire (US)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10049.3549.3549.3500DE
40049.3549.3549.3500DE
120049.3549.3549.3500DE
260049.3549.3549.3500DE
520049.3549.3549.3500DE
1560049.3549.3549.3500DE
2600049.3549.3549.35149.35DE

0RN3 - Frequently Asked Questions (FAQ)

What is the current Takeda Pharmaceutical share price?
The current share price of Takeda Pharmaceutical is 49,35 €
How many Takeda Pharmaceutical shares are in issue?
Takeda Pharmaceutical has 1 582 419 000 shares in issue
What is the market cap of Takeda Pharmaceutical?
The market capitalisation of Takeda Pharmaceutical is EUR 78,09B
What is the 1 year trading range for Takeda Pharmaceutical share price?
Takeda Pharmaceutical has traded in the range of 49,35 € to 49,35 € during the past year
What is the PE ratio of Takeda Pharmaceutical?
The price to earnings ratio of Takeda Pharmaceutical is 0,29
What is the cash to sales ratio of Takeda Pharmaceutical?
The cash to sales ratio of Takeda Pharmaceutical is 0,01
What is the reporting currency for Takeda Pharmaceutical?
Takeda Pharmaceutical reports financial results in JPY
What is the latest annual turnover for Takeda Pharmaceutical?
The latest annual turnover of Takeda Pharmaceutical is JPY 4,28T
What is the latest annual profit for Takeda Pharmaceutical?
The latest annual profit of Takeda Pharmaceutical is JPY 144,07B
What is the registered address of Takeda Pharmaceutical?
The registered address for Takeda Pharmaceutical is 4-1-1 DOSHOMACHI, CHUO-KU, CHUO, TOKYO, 540-8645
What is the Takeda Pharmaceutical website address?
The website address for Takeda Pharmaceutical is www.takeda.co.jp
Which industry sector does Takeda Pharmaceutical operate in?
Takeda Pharmaceutical operates in the PHARMACEUTICAL DIVERSIFIED sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
AIQAiq Limited
4,00p
(33,33%)
37,88k
INSPInspirit Energy Holdings Plc
0,0036p
(28,57%)
1,43B
ALKAlkemy Capital Investments Plc
175,00p
(27,27%)
176,27k
KNBKanabo Group Plc
1,00p
(25,00%)
461,04k
TCFTheracryf Plc
1,125p
(25,00%)
6,72M
MET1Metals One Plc
0,275p
(-35,29%)
16,2M
PPSProton Motor Power Systems Plc
0,175p
(-22,22%)
848,7k
SYMESupply@me Capital Plc
0,0025p
(-19,35%)
372,49M
CGNRConroy Gold & Natural Resources Plc
2,15p
(-18,87%)
739,53k
ONCOncimmune Holdings Plc
10,40p
(-16,47%)
1,19M
INSPInspirit Energy Holdings Plc
0,0036p
(28,57%)
1,43B
NTVONativo Resources Plc
0,0018p
(-5,26%)
1,41B
MSMNMosman Oil And Gas Limited
0,041p
(10,81%)
1,22B
TRPTower Resources Plc
0,0295p
(0,00%)
691,76M
SYMESupply@me Capital Plc
0,0025p
(-19,35%)
372,49M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

LSE
0RN3
Takeda Pharmaceutical
BIT
P1R9J4
BNP Paribas Issuance
BIT
P16KY8
BNP Paribas Issuance
BIT
P1PWU1
BNP Paribas Issuance
BIT
EXUS
ETF
BIT
3SIL
WisdomTree Silver 3x Dai...
LSE
CRDL
Cordel
BIT
XUEM
Xtrackers Ii Usd Emergin...
BIT
P1TKR4
BNP Paribas Issuance
BIT
S24907
SG ISSUER
BIT
UC6MQH
Unicredit Bank
BIT
P1QSO0
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces